24 Sep 2021 --- Atmo Biosciences has raised AU$9.6 million (US$7.0 million) to accelerate product development of its gas-sensing capsule. The device detects clinically important gaseous biomarkers produced by the gut microbiome as it travels through a person’s gastrointestinal system and transmits the data to the cloud for analysis.